EA199700199A1 - 4-аминотетрагидробензизоксазоловые или -изотиазоловые соединения, их применение и фармацевтическая композиция на их основе - Google Patents

4-аминотетрагидробензизоксазоловые или -изотиазоловые соединения, их применение и фармацевтическая композиция на их основе

Info

Publication number
EA199700199A1
EA199700199A1 EA199700199A EA199700199A EA199700199A1 EA 199700199 A1 EA199700199 A1 EA 199700199A1 EA 199700199 A EA199700199 A EA 199700199A EA 199700199 A EA199700199 A EA 199700199A EA 199700199 A1 EA199700199 A1 EA 199700199A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
application
isothiazolic
aminothetrahydrobenzisoxasolic
basis
Prior art date
Application number
EA199700199A
Other languages
English (en)
Other versions
EA000380B1 (ru
Inventor
Эрик Фальк
Енс Кристьян Перрегор
Арне Скоусбо
Повл Крогсгор-Ларсен
Бенте Фрёлунн
Ленс Сибюлле Мольтсен
Original Assignee
Х.Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Х.Лундбекк А/С filed Critical Х.Лундбекк А/С
Publication of EA199700199A1 publication Critical patent/EA199700199A1/ru
Publication of EA000380B1 publication Critical patent/EA000380B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nozzles (AREA)

Abstract

4-Аминотетрагидробензизоксазоловые или -изотиазоловые соединения, имеющие общую формулу (Ia) и (Ib)где R-R, X и P определены в описании. Раскрываемые соединения обладают ГАМК-(4-аминомасляная кислота)-ингибирующей активностью и могут использоваться при лечении анальгезии, психоза, судорог, беспокойства или мышечных или двигательных расстройств, в особенности эпилепсии.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199700199A 1995-02-28 1996-02-28 4-аминотетрагидробензизоксазоловые или -изотиазоловые соединения, их применение и фармацевтическая композиция на их основе EA000380B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK20795 1995-02-28
PCT/DK1996/000084 WO1996026929A1 (en) 1995-02-28 1996-02-28 4-aminotetrahydrobenzisoxazole or -isothiazole compounds

Publications (2)

Publication Number Publication Date
EA199700199A1 true EA199700199A1 (ru) 1998-02-26
EA000380B1 EA000380B1 (ru) 1999-06-24

Family

ID=8090951

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199700199A EA000380B1 (ru) 1995-02-28 1996-02-28 4-аминотетрагидробензизоксазоловые или -изотиазоловые соединения, их применение и фармацевтическая композиция на их основе

Country Status (31)

Country Link
US (2) US5998613A (ru)
EP (1) EP0812318B1 (ru)
JP (1) JPH11501016A (ru)
KR (1) KR100242675B1 (ru)
CN (1) CN1087290C (ru)
AT (1) ATE317391T1 (ru)
AU (1) AU697610B2 (ru)
BG (1) BG63258B1 (ru)
BR (1) BR9607443A (ru)
CA (1) CA2213127A1 (ru)
CZ (1) CZ290837B6 (ru)
DE (1) DE69635798T2 (ru)
DK (1) DK0812318T3 (ru)
EA (1) EA000380B1 (ru)
EE (1) EE03483B1 (ru)
ES (1) ES2253748T3 (ru)
FI (1) FI973519A0 (ru)
HK (1) HK1008527A1 (ru)
HU (1) HUP9800631A3 (ru)
IL (1) IL117295A (ru)
IS (1) IS2352B (ru)
NO (1) NO309474B1 (ru)
NZ (1) NZ301653A (ru)
PL (1) PL187404B1 (ru)
RO (1) RO119545B1 (ru)
SI (1) SI0812318T1 (ru)
SK (1) SK281879B6 (ru)
TR (1) TR199700873T1 (ru)
UA (1) UA43396C2 (ru)
WO (1) WO1996026929A1 (ru)
ZA (1) ZA961591B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0934061T6 (en) 1996-07-24 2015-01-26 Warner Lambert Co Isobutylgaba and its derivatives for the treatment of pain
GB9622370D0 (en) * 1996-10-28 1997-01-08 Merck Sharp & Dohme Therapeutic agents
US20030185754A1 (en) * 2001-01-16 2003-10-02 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US20030166554A1 (en) * 2001-01-16 2003-09-04 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US7417040B2 (en) * 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7378426B2 (en) * 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US8178522B2 (en) * 2009-05-05 2012-05-15 Hoffmann-La Roche Inc. Thiazoles
ES2885698T3 (es) 2009-06-25 2021-12-15 Alkermes Pharma Ireland Ltd Profármacos de compuestos nh-ácidos
CN105758807B (zh) * 2016-02-22 2019-01-29 山东出入境检验检疫局检验检疫技术中心 一种鉴别废润滑油的方法
CN112423754A (zh) 2018-03-05 2021-02-26 奥克梅斯制药爱尔兰有限公司 阿立哌唑的给药策略

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2602643C2 (de) * 1976-01-24 1984-12-20 Bayer Ag, 5090 Leverkusen 1,2-Benzisothiazolinone-3, Verfahren zu ihrer Herstellung sowie Arzneimittel
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4514414A (en) * 1982-10-25 1985-04-30 Smithkline Beckman Corporation N-Substituted pyrrolidineacetic acids and their esters
US4804663A (en) 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
US5321037A (en) * 1986-12-26 1994-06-14 Sankyo Company, Limited Isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants
ZA879631B (en) * 1986-12-26 1989-08-30 Sankyo Co Centrally-acting muscle relaxants
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
US5225412A (en) * 1991-04-29 1993-07-06 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides

Also Published As

Publication number Publication date
ZA961591B (en) 1996-08-28
PL321956A1 (en) 1998-01-05
EP0812318A1 (en) 1997-12-17
IL117295A0 (en) 1996-06-18
AU4713196A (en) 1996-09-18
AU697610B2 (en) 1998-10-15
CZ290837B6 (cs) 2002-10-16
ATE317391T1 (de) 2006-02-15
HK1008527A1 (en) 1999-07-30
NZ301653A (en) 1998-12-23
DE69635798T2 (de) 2006-08-17
HUP9800631A2 (hu) 1998-08-28
BR9607443A (pt) 1998-05-26
ES2253748T3 (es) 2006-06-01
FI973519A (fi) 1997-08-27
EA000380B1 (ru) 1999-06-24
WO1996026929A1 (en) 1996-09-06
EE03483B1 (et) 2001-08-15
JPH11501016A (ja) 1999-01-26
NO973948L (no) 1997-08-27
MX9706280A (es) 1998-06-30
CN1087290C (zh) 2002-07-10
HUP9800631A3 (en) 1998-12-28
FI973519A0 (fi) 1997-08-27
EE9700197A (et) 1998-02-16
CA2213127A1 (en) 1996-09-06
CZ271197A3 (cs) 1998-03-18
SK281879B6 (sk) 2001-08-06
US5998613A (en) 1999-12-07
NO309474B1 (no) 2001-02-05
IS2352B (is) 2008-04-15
SK115197A3 (en) 1998-02-04
EP0812318B1 (en) 2006-02-08
IL117295A (en) 1999-11-30
DE69635798D1 (de) 2006-04-20
RO119545B1 (ro) 2004-12-30
KR100242675B1 (ko) 2000-03-02
BG63258B1 (bg) 2001-07-31
DK0812318T3 (da) 2006-06-06
IS4542A (is) 1997-08-13
SI0812318T1 (sl) 2006-06-30
PL187404B1 (pl) 2004-07-30
NO973948D0 (no) 1997-08-27
UA43396C2 (uk) 2001-12-17
TR199700873T1 (xx) 1998-01-21
BG101894A (en) 1998-05-29
KR19980702546A (ko) 1998-07-15
CN1176638A (zh) 1998-03-18
US6174909B1 (en) 2001-01-16

Similar Documents

Publication Publication Date Title
PL298195A1 (en) Sulfonamido- and sulfonabidocabonyl-pyridine-2-carboxylic acid amides and their pyridine-n-oxides, method of obtaining them and their application as therapeutic agents as well therapeutic agents containing them and method of obtaining such therapeutic
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
BR9909382A (pt) Anticorpo humanizado contra o fator tissular humano (tf) e processo de produção de anticorpo humanizado
EE9900539A (et) Uued ühendid
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
TR200101859T2 (tr) Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler
EA199900632A1 (ru) 2-амино-6-(2-замещенные-4-фенокси)-замещенные-пиридины
CA2304657A1 (en) Treatment of conduct disorder
FR2764887B1 (fr) Melange de diphenylamines nonylees, procede pour le preparer et composition le contenant
DE69615682D1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h-benzo[b][1,5]-diazepin-3-yl)-acetamide
FI974447A (fi) Semikarbatsonit, joilla on keskushermostoaktiivisuutta, ja niitä sisältävät farmaseuttiset valmisteet
EA199700199A1 (ru) 4-аминотетрагидробензизоксазоловые или -изотиазоловые соединения, их применение и фармацевтическая композиция на их основе
WO1992019617A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
EA200100342A1 (ru) Связывающие соединения адгезионной молекулы нервной клетки
EA200000741A1 (ru) Новые производные дигидроксигексановой кислоты
ATE160561T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
ATE266663T1 (de) Acrylamid-derivate und verfahren zu deren herstellung
DE69414194D1 (de) Aminosäurederivate und ihre Verwendung als Enkephalinase-Inhibitoren
BG102342A (en) Optical active derivative of phenylpyrimidine as an anlgesics
DE69613395D1 (de) Schwefelenthaltende di-ter-butylphenol-verbindungen brauchbar als entzündungshemmende mittel
DK0626367T3 (da) (7S)-7- (2R)-2-(3-chlorphenyl)-2-hydroxyethylamino -5,6,7,8-tetrahydronapthalen-2-yloxyeddikesyre og farmaceutisk acceptable salte deraf med beta3-adrenerg agonistvirkning, farmaceutiske præparater og laboratoriereagenser som indeholder den.
MXPA04004826A (es) Antagonista del receptor de quimioquinas y metodos para su uso.
AP2000001937A0 (en) Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway.
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM